Satellos Bioscience Inc.
Pharmaceutical company · Markham, Ontario, Canada · Nasdaq: MSLE
Satellos Bioscience Inc. is a pharmaceutical company headquartered in Markham, Ontario, Canada. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker MSLE. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2025.
Satellos Bioscience at a glance
What does Satellos Bioscience do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $25 million sold (2025).
Frequently asked questions about Satellos Bioscience
Where is Satellos Bioscience headquartered?
Satellos Bioscience Inc. is headquartered in Markham, Ontario, Canada.
What does Satellos Bioscience do?
Satellos Bioscience Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Satellos Bioscience a public company?
Yes. Satellos Bioscience Inc. trades on Nasdaq under the ticker MSLE.
When was Satellos Bioscience founded?
The earliest incorporation on record for Satellos Bioscience Inc. is in 2021, according to public company registers.
Similar companies
- Edesa Biotech, Inc.Markham, Ontario, Canada
- Aurinia Pharmaceuticals Inc.Edmonton, Alberta, Canada
- AbCellera Biologics Inc.Vancouver, British Columbia, Canada
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- Eupraxia Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- Lexaria Bioscience Corp.Kelowna, British Columbia, Canada
- InMed Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- Clearmind Medicine Inc.Vancouver, British Columbia, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.